HK1102808A1 - (r/s) rifamycin derivatives, their preparation and pharmaceutical compositions - Google Patents
(r/s) rifamycin derivatives, their preparation and pharmaceutical compositionsInfo
- Publication number
- HK1102808A1 HK1102808A1 HK07110800.2A HK07110800A HK1102808A1 HK 1102808 A1 HK1102808 A1 HK 1102808A1 HK 07110800 A HK07110800 A HK 07110800A HK 1102808 A1 HK1102808 A1 HK 1102808A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- sub
- rifamycin derivatives
- preparation
- humans
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59019004P | 2004-07-22 | 2004-07-22 | |
PCT/US2005/025924 WO2006012443A1 (fr) | 2004-07-22 | 2005-07-21 | Derives de la rifamycine (r/s), leur preparation et compositions pharmaceutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1102808A1 true HK1102808A1 (en) | 2007-12-07 |
Family
ID=35355764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07110800.2A HK1102808A1 (en) | 2004-07-22 | 2007-10-04 | (r/s) rifamycin derivatives, their preparation and pharmaceutical compositions |
Country Status (11)
Country | Link |
---|---|
US (2) | US7226931B2 (fr) |
EP (2) | EP1768987B1 (fr) |
JP (2) | JP5153329B2 (fr) |
CN (2) | CN101031572B (fr) |
AT (1) | ATE427311T1 (fr) |
AU (1) | AU2005267054B2 (fr) |
CA (2) | CA2574301C (fr) |
DE (1) | DE602005013671D1 (fr) |
HK (1) | HK1102808A1 (fr) |
NZ (1) | NZ565002A (fr) |
WO (2) | WO2006012443A1 (fr) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6541014B2 (en) * | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
US20020068078A1 (en) * | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US20020197314A1 (en) * | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
US8425936B2 (en) * | 2003-07-21 | 2013-04-23 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
AU2004258953B2 (en) * | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
JP2006528189A (ja) * | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質産物、その使用法および製剤 |
CA2535177A1 (fr) | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Pastille robuste |
AU2004264356B2 (en) * | 2003-08-12 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
WO2005023184A2 (fr) * | 2003-08-29 | 2005-03-17 | Advancis Pharmaceuticals Corporation | Produit antibiotique, son utilisation et sa formulation |
CA2538064C (fr) * | 2003-09-15 | 2013-12-17 | Advancis Pharmaceutical Corporation | Antibiotique, son utilisation et sa formulation |
ES2537976T3 (es) | 2003-12-12 | 2015-06-16 | Daiichi Sankyo Company, Limited | Compuestos intermedios para la producción de derivados de ciclopropilamina ópticamente activos y procedimiento para la producción de los compuestos intermedios |
EP1771158A4 (fr) * | 2004-07-02 | 2008-03-12 | Advancis Pharmaceutical Corp | Comprimé pour distribution par impulsion |
GB0505909D0 (en) * | 2005-03-23 | 2005-04-27 | Univ Leeds | Formulations |
AU2006339058B2 (en) | 2005-08-11 | 2012-09-06 | Targanta Therapeutics Inc. | Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
US7892826B2 (en) | 2005-08-15 | 2011-02-22 | Janssen Pharmaceutica N.V. | Human cell clones having an endogeneous urotensin II receptor |
US8778924B2 (en) * | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8299052B2 (en) * | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
TWI454262B (zh) * | 2006-11-02 | 2014-10-01 | Targacept Inc | 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺 |
WO2009064792A1 (fr) * | 2007-11-16 | 2009-05-22 | Cumbre Pharmaceuticals Inc. | Dérivés de rifamycine substituée par l'acide quinolone-carboxylique |
US8067429B2 (en) | 2008-02-25 | 2011-11-29 | Salix Pharmaceuticals, Ltd. | Forms of rifaximin and uses thereof |
US8486956B2 (en) | 2008-02-25 | 2013-07-16 | Salix Pharmaceuticals, Ltd | Forms of rifaximin and uses thereof |
CN101959888A (zh) * | 2008-03-05 | 2011-01-26 | 塔加西普特公司 | 二氮杂双环烷烃的烟碱乙酰胆碱受体亚型的选择性酰胺 |
US8278313B2 (en) * | 2008-03-11 | 2012-10-02 | Abbott Laboratories | Macrocyclic spiro pyrimidine derivatives |
EP2324041A4 (fr) | 2008-08-13 | 2012-06-13 | Targanta Therapeutics Corp | Rifamycines phosphonées et leurs utilisations pour la prévention et le traitement d'infections des os et des articulations |
CN101875658B (zh) * | 2009-04-28 | 2013-01-09 | 上海药明康德新药开发有限公司 | 3-羰基-2,8-二氮杂螺[4.5] 癸烷-8-羧酸叔丁酯的制备方法 |
MX2012004753A (es) | 2009-10-23 | 2012-09-07 | Janssen Pharmaceutica Nv | Octahidropirrolo[3,4-c]pirrolos disustituidos como moduladores del receptor de orexina. |
NZ604035A (en) | 2010-06-04 | 2015-02-27 | Albany Molecular Res Inc | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
BR112015002945B1 (pt) * | 2012-08-13 | 2021-08-31 | Adipharm Ead | Formulações farmacêuticas contendo derivados de 3-(4-cinamil-1-piperazinil)-amino de 3- formil-rifamicina sv e 3-formil-rifamicina s e um processo para sua preparação |
CN104955457A (zh) * | 2012-09-12 | 2015-09-30 | 萨利克斯药品公司 | 给予利福昔明而不产生抗生素耐药性的方法 |
CN103709177B (zh) * | 2013-12-20 | 2016-02-24 | 武汉工程大学 | 利福霉素类沃尼妙林杂合抗生素及其制备方法 |
CN104628745B (zh) * | 2015-03-06 | 2017-03-08 | 丹诺医药(苏州)有限公司 | 一种利福霉素‑喹嗪酮双靶标分子的富马酸盐及其制备方法 |
CN104710439B (zh) * | 2015-03-06 | 2017-11-07 | 丹诺医药(苏州)有限公司 | 一种利福霉素‑喹嗪酮双靶标分子的晶型i及其制备方法 |
MA43817B1 (fr) | 2016-03-10 | 2022-04-29 | Janssen Pharmaceutica Nv | Méthodes de traitement de la dépression à l'aide d'antagonistes de récepteurs de l'orexine-2 |
CN105879009A (zh) * | 2016-04-18 | 2016-08-24 | 丹诺医药(苏州)有限公司 | 一种用于治疗革兰氏阴性菌感染的抗菌药物组合物 |
WO2017212423A1 (fr) * | 2016-06-08 | 2017-12-14 | Glaxosmithkline Intellectual Property Development Limited | Composés chimiques |
CN106902116B (zh) * | 2017-02-28 | 2021-03-23 | 丹诺医药(苏州)有限公司 | 一种利福霉素-喹嗪酮双靶标分子的应用 |
CN106822125A (zh) * | 2017-02-28 | 2017-06-13 | 丹诺医药(苏州)有限公司 | 一种利福霉素‑喹嗪酮双靶标分子的新用途 |
CN109251258B (zh) * | 2017-07-13 | 2021-06-01 | 中国石油天然气股份有限公司 | 宽分布聚丙烯催化组分、组分制备方法及其催化剂 |
WO2019027860A1 (fr) * | 2017-08-01 | 2019-02-07 | Boehringer Ingelheim International Gmbh | Composés intermédiaires et procédés |
CN108310393A (zh) * | 2018-02-12 | 2018-07-24 | 丹诺医药(苏州)有限公司 | 一种利福霉素-喹嗪酮偶联分子的应用 |
CN109464673A (zh) * | 2019-01-08 | 2019-03-15 | 丹诺医药(苏州)有限公司 | 利福霉素-喹嗪酮偶联分子及其盐的应用和制剂 |
CN109529045B (zh) * | 2019-01-08 | 2021-05-18 | 丹诺医药(苏州)有限公司 | 利福霉素-喹嗪酮偶联分子及其药学上可接受的盐的应用 |
CN109942474B (zh) * | 2019-03-04 | 2020-09-18 | 华中科技大学 | 一种邻叠氮-肼类化合物及其制备方法 |
CN115501230B (zh) * | 2022-08-05 | 2023-11-21 | 丹诺医药(苏州)有限公司 | 利福霉素-喹嗪酮偶联分子软膏剂及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0333176B1 (fr) * | 1988-03-18 | 1995-11-08 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Dérivé de la benzoxazinorifamycine substitué, procédé de préparation et agent antibactérien le contenant |
WO1994028002A1 (fr) * | 1993-05-24 | 1994-12-08 | Gruppo Lepetit S.P.A. | Derives-36 de rifamycines et leur utilisation comme agents anti-microbiens |
AU2002360416A1 (en) * | 2001-11-21 | 2003-06-10 | Activbiotics, Inc. | Targeted therapeutics and uses thereof |
US7247634B2 (en) * | 2004-01-13 | 2007-07-24 | Cumbre Pharmaceuticals Inc. | Rifamycin derivatives effective against drug-resistant microbes |
US7238694B2 (en) * | 2004-01-13 | 2007-07-03 | Cumbre Pharmaceuticals, Inc. | Rifamycin imino derivatives effective against drug-resistant microbes |
-
2005
- 2005-07-21 DE DE602005013671T patent/DE602005013671D1/de active Active
- 2005-07-21 EP EP05791212A patent/EP1768987B1/fr active Active
- 2005-07-21 WO PCT/US2005/025924 patent/WO2006012443A1/fr active Application Filing
- 2005-07-21 NZ NZ565002A patent/NZ565002A/en active Application Filing
- 2005-07-21 CA CA2574301A patent/CA2574301C/fr active Active
- 2005-07-21 JP JP2007522765A patent/JP5153329B2/ja active Active
- 2005-07-21 AU AU2005267054A patent/AU2005267054B2/en active Active
- 2005-07-21 WO PCT/US2005/025969 patent/WO2006012470A1/fr active Application Filing
- 2005-07-21 EP EP05773711A patent/EP1781670A1/fr not_active Withdrawn
- 2005-07-21 CA CA002574307A patent/CA2574307A1/fr not_active Abandoned
- 2005-07-21 JP JP2007522780A patent/JP5236944B2/ja active Active
- 2005-07-21 AT AT05791212T patent/ATE427311T1/de not_active IP Right Cessation
- 2005-07-21 CN CN2005800308596A patent/CN101031572B/zh active Active
- 2005-07-21 US US11/186,425 patent/US7226931B2/en active Active
- 2005-07-21 CN CNA2005800316554A patent/CN101065385A/zh active Pending
- 2005-07-21 US US11/186,187 patent/US7229996B2/en active Active
-
2007
- 2007-10-04 HK HK07110800.2A patent/HK1102808A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US7226931B2 (en) | 2007-06-05 |
WO2006012470A1 (fr) | 2006-02-02 |
EP1781670A1 (fr) | 2007-05-09 |
AU2005267054A1 (en) | 2006-02-02 |
CN101065385A (zh) | 2007-10-31 |
DE602005013671D1 (de) | 2009-05-14 |
EP1768987A1 (fr) | 2007-04-04 |
JP5153329B2 (ja) | 2013-02-27 |
EP1768987B1 (fr) | 2009-04-01 |
US20060019985A1 (en) | 2006-01-26 |
US7229996B2 (en) | 2007-06-12 |
WO2006012443A1 (fr) | 2006-02-02 |
CN101031572B (zh) | 2010-12-08 |
CA2574301A1 (fr) | 2006-02-02 |
CA2574307A1 (fr) | 2006-02-02 |
ATE427311T1 (de) | 2009-04-15 |
NZ565002A (en) | 2009-08-28 |
CA2574301C (fr) | 2013-09-10 |
CN101031572A (zh) | 2007-09-05 |
JP5236944B2 (ja) | 2013-07-17 |
JP2008507549A (ja) | 2008-03-13 |
US20060019986A1 (en) | 2006-01-26 |
AU2005267054B2 (en) | 2011-06-23 |
JP2008507548A (ja) | 2008-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1102808A1 (en) | (r/s) rifamycin derivatives, their preparation and pharmaceutical compositions | |
WO2010032147A3 (fr) | Dérivés d'acide hydroxamique utiles comme agents antibactériens | |
WO2003010135A1 (fr) | Nouveaux derives de l'acide phenylpropionique | |
GB0007405D0 (en) | Compounds | |
KR20050085991A (en) | Compounds exhibiting thrombopoietin receptor agonism | |
WO2008108386A1 (fr) | Composition pharmaceutique | |
TW200628161A (en) | Novel betulin derivatives, preparation thereof and use thereof | |
EP2266623A3 (fr) | Promédicaments contenant de nouveaux liens bio-clivables | |
AU2003222106A1 (en) | Thiopene-based tricyclic compounds and pharmaceutical compositions comprising same | |
MX2009003927A (es) | Derivado espirocetal de tioglucosa y uso del mismo como un agente terapeutico para la diabetes. | |
WO2008151460A3 (fr) | Composés de refroidissement | |
NZ320580A (en) | Tricyclic compounds, preparation and pharmaceutical compositions thereof | |
BRPI0408240A (pt) | composto, utilização de um composto e composição farmacêutica | |
MY141472A (en) | Substituted phenyl phenol leukotriene antagonists | |
WO2007080270A3 (fr) | Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation | |
TW200745153A (en) | Trehalose compound and pharmaceutical comprising the compound | |
MX2007002531A (es) | Derivados novedosos de 3,5-seco-4-norcolestan y usos de los mismos. | |
AU2001282871A1 (en) | Antithrombotic agents | |
WO2007044927A3 (fr) | Macrolides tricycliques a pontage 6, 11 | |
TR200200550T2 (tr) | Piruvat dehidrojenaz aktivitesini yükselten ikameli n-fenil 2-hidroksi -2- metil -3,3,3- triflüoropropanamid türevleri. | |
AU2003294031A1 (en) | Dust-free pigment compositions obtainable by spray-drying | |
RS20050837A (en) | NEW 3-DECLADINOSYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES OF 9-DEOX-9-DIHYDRO-9a-AZA-9A- HOMOERYTHROMYCIN A NEW 3- DECLADINOSYL 9A-N-CARBAMOYL AND -A- N-THIOCARBAMOYL DERIVATIVES OF 9- DEOX-9-DIHYDRO-9A-AZA-9A- HOMOERYTHROMYCIN A | |
RS20050954A (en) | Use of bycyclo/2.2.1/heptane derivatives for the preparation of neuroprotective pharmaceutical compositions | |
NZ515278A (en) | Halo derivatives of 9-deoxo-9a-aza-9a- homerythromycin A their salts and preparation process | |
WO2000064902A3 (fr) | Processus de preparation de precurseurs de calanolide |